December 2021


The next meeting of the NAFLD SIG will take place in the afternoon on Friday 10th December and will be held at: 

Blizard Institute
Barts and The London School of Medicine and Dentistry
Queen Mary University of London
4 Newark St
E1 2AT

A remote channel is being explored for those who cannot attend in person.  

Members of the NAFLD SIG have been sent the details on how to register for the meeting and all enquiries should be directed to . 

BASL Virtual School of Hepatology December 2021 - Session 12: Care of the advanced liver disease patient, with and without transplantation


Are you a budding Hepatologist? Do you want to improve your Hepatology knowledge to help with core and higher Hepatology curriculum sign off? Have you got Hepatology questions but not had the opportunity to ask them?

If yes then please join us for the BASL Virtual School of Hepatology 2021. We are running a series of monthly webinars on a Wednesday evening.

Session 12: "Care of the advanced liver disease patient, with and without transplantation"
Speaker:  Dr Ben Hudson, Royal Devon and Exeter Hospital
Date: Wednesday 15th December
UK Time: 19:00 – 20:00

The BASL Virtual School of Hepatology Sessions offer an excellent platform for trainees interested in hepatology, with talks delivered by UK Hepatologists, followed by a Q&A session.

Preview the series programme  Download BASL Virtual School of Hepatology Series 2021_website7.pdf
NB: Subject to change

FREE to attend for BASL Members.

Not a member of BASL, then why not join by clicking > here.

REGISTER - through Zoom by clicking here .

Remember to read the BASL Events Data Protection Disclaimer below before registering:

Download BASL Events Data Protection Disclaimer_2021.pdf

Please contact should you have any questions.

Thank you to our supporters:

     Platinum Sponsor:                                                       Gold Sponsor:                         Bronze Sponsor:

'This webinar series is supported by Shionogi, Dr Falk Pharma UK and Intercept Pharma UK & Ireland. They have had no influence or input into the programme, agenda or content of the meeting’.

January 2022

British Hepatology Pharmacy Group Meeting - Save the Date

Save the Date

A provisional date has been set for the next BHPG eduational meeting. 

The meeting will take place as a Zoom webinar and further details will be added once confirmed. 

Contact should you have any questions.

BASL CCA-UK SIG Virtual Annual Conference - Save the Date

Save the Date 

The BASL CCA-UK SIG Virtual Annual Conference will be taking place on Thursday 20th January 2022 from 14:00 - 18:00 UK time. 

A draft programme is below:

Exploring Clinical Advances in Cholangiocarcinoma

14:00 – 14:15 Welcome - Prof Shahid Khan, Imperial College, London
14:15 – 14:45 Status of targeted therapy for CCA in the UK – testing and treatment: Prof Juan Valle, Christie NHS Foundation Trust & Prof John Bridgewater, University College London
14:45 - 15:15 Update on Transplantation for CCA: which patients, protocol? Mr Raj Prasad, Leeds Teaching Hospitals NHS Trust
15:15 - 15:30 Industry Symposia: parallel sessions
15:30 - 15:45 Break
15:45 - 16:15 Outcomes of the CCA England data project: HDI or Prof Shahid Khan, Imperial College, London
16:15 - 17:00 DEBATE: Do we need CCA centres of expertise?
FOR: Mr Hassan Malik, ‎Aintree University Hospital, Liverpool;
AGAINST: Prof Derek Manas, Freeman Hospital, Newcastle
17:00 – 17:20 Update on ENSCCA & COST ACTION: Prof Jesus Banales, Basic Science expert and Head of the Liver Diseases Group at the BioDonostia Institute, Donostia University Hospital, San Sebastian (Spain)
17:20 – 17:40 Managing Patient Expectations: Louise Jones & Margaret Griffin, Aintree University, Hospital, Liverpool
17:40 – 18:00 Research Gaps & Future Trials: Prof Juan Valle, Christie NHS Foundation Trust

Further details will follow when available.

Contact . 

March 2022

HCC-UK Annual Conference 2022

The HCC-UK Committee are delighted to announce the dates for their Annual Conference 2022.

The meeting is directed towards all those involved in the care of patients with HCC including hepatologists, gastroenterologists, radiologists, oncologists, surgeons and clinical nurse specialists and scientists.

Further details will be announced soon.